Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 15 results.
User Information
Export Records
  1. 1.   Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4+Foxp3+ regulatory T cells
  2. He, Tianzhen; Yang,De; Li, Xiao-Qing; Jiang, Mengmeng; Islam, Md Sahidul; Chen, Shaokui; Chen, Yibo; Yang, Yang; Chou, Chon-Kit; Trivett,Anna; Oppenheim,Joost; Chen, Xin
  3. Science advances. 2020, Sep; 6(40): pii: eaba6584.
  1. 2.   STATE-OF-THE-ART THERAPEUTIC MEDICAL COUNTERMEASURES FOR VIRAL THREAT AGENTS
  2. Sampath, A.; Metz, M.; Stundick, M.; Larsen, J. C.
  3. Biosecurity and Bioterrorism-Biodefense Strategy Practice and Science. 2011, Dec; 9(4): 351-360.
  1. 3.   A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial
  2. Ledgerwood, J. E.; Pierson, T. C.; Hubka, S. A.; Desai, N.; Rucker, S.; Gordon, I. J.; Enama, M. E.; Nelson, S.; Nason, M.; Gu, W. J.; Bundrant, N.; Koup, R. A.; Bailer, R. T.; Mascola, J. R.; Nabel, G. J.; Graham, B. S.; Team, V. R. C. S.
  3. Journal of Infectious Diseases. 2011, May; 203(10): 1396-1404.
  1. 4.   Smallpox Vaccine Safety Is Dependent on T Cells and Not B Cells
  2. Gordon, S. N.; Cecchinato, V.; Andresen, V.; Heraud, J. M.; Hryniewicz, A.; Parks, R. W.; Venzon, D.; Chung, H. K.; Karpova, T.; McNally, J.; Silvera, P.; Reimann, K. A.; Matsui, H.; Kanehara, T.; Shinmura, Y.; Yokote, H.; Franchini, G.
  3. Journal of Infectious Diseases. 2011, Apr; 203(8): 1043-1053.
  1. 5.   The Nitric Oxide Prodrug V-PROLI/NO Inhibits Cellular Uptake of Proline
  2. Hong, S. Y.; Borchert, G. L.; Maciag, A. E.; Nandurdikar, R. S.; Saavedra, J. E.; Keefer, L. K.; Phang, J. M.; Chakrapani, H.
  3. Acs Medicinal Chemistry Letters. 2010, Nov; 1(8): 386-389.
  1. 6.   NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway
  2. Watanabe, T.; Asano, N.; Fichtner-Feigl, S.; Gorelick, P. L.; Tsuji, Y.; Matsumoto, Y.; Chiba, T.; Fuss, I. J.; Kitani, A.; Strober, W.
  3. Journal of Clinical Investigation. 2010, May; 120(5): 1645-1662.
  1. 7.   Probiotics: From Bench to Market
  2. Klein, M.; Sanders, M. E.; Duong, T.; Young, H. A.
  3. Probiotics: From Bench to Market. 2010; 1212 : E1-E14.
  1. 8.   An improved synthesis of V-PROLI/NO, a cytochrome P450-activated nitric oxide prodrug
  2. Hong, S. Y.; Nandurdikar, R. S.; Keefer, L. K.; Saavedra, J. E.; Chakrapani, H.
  3. Tetrahedron Letters. 2009 50(31): 4545-4548.
  1. 9.   Improved synthesis of V-PYRRO/NO, a liver-selective nitric oxide prodrug, and analogues
  2. Hong, S. Y.; Saavedra, J. E.; Keefer, L. K.; Chakrapani, H.
  3. Tetrahedron Letters. 2009 50(18): 2069-2071.
  1. 10.   V-PROLI/NO, a prodrug of the nitric oxide donor, PROLI/NO
  2. Chakrapani, H.; Showalter, B. M.; Kong, L.; Keefer, L. K.; Saavedra, J. E.
  3. Organic Letters. 2007, Aug; 9(17): 3409-3412.
  1. 11.   Metabolism of a liver-selective nitric oxide-releasing agent, V-PYRRO/NO, by human microsomal cytochromes P450
  2. Inami, K.; Nims, R. W.; Srinivasan, A.; Citro, M. L.; Saavedra, J. E.; Cederbaum, A. I.; Keefer, L. K.
  3. Nitric Oxide-Biology and Chemistry. 2006, Jun; 14(4): 309-315.
  1. 12.   Endogenous leukemia inhibitory factor attenuates endotoxin response
  2. Weber, M. A.; Schnyder-Candrian, S.; Schnyder, B.; Quesniaux, V.; Poli, V.; Stewart, C. L.; Ryffel, B.
  3. Laboratory Investigation. 2005, FEB; 85(2): 276-284.
  1. 13.   Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models
  2. Cao, B.; Su, Y. L.; Oskarsson, M.; Zhao, P.; Kort, E. J.; Fisher, R. J.; Wang, L. M.; Vande Woude, G. F.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2001 98(13): 7443-7448.
  1. 14.   Metallothionein and Apoptosis in Primary Human Hepatocellular Carcinoma and Metastatic Adenocarcinoma
  2. Deng, D. X.; Chakrabarti, S.; Waalkes, M. P.; Cherian, M. G.
  3. Histopathology. 1998 32(4): 340-347.
  1. 15.   The Cytotoxicity of Nitroxyl - Possible Implications For the Pathophysiological Role of No
  2. Wink, D. A.; Feelisch, N.; Fukuto, J.; Chistodoulou, D.; Jourdheuil, D.; Grisham, M. B.; Vodovotz, Y.; Cook, J. A.; Krishna, M.; Degraff, W. G.; Kim, S.; Gamson, J.; Mitchell, J. B.
  3. Archives of Biochemistry and Biophysics. 1998 351(1): 66-74.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel